Partridge K - Search Results

1

Biological and mechanical enhancement of impacted allograft seeded with human bone marrow stromal cells: potential clinical role in impaction bone grafting.

Bolland BJ, Partridge K, Tilley S, New AM, Dunlop DG, Oreffo RO. Bolland BJ, et al. Among authors: partridge k. Regen Med. 2006 Jul;1(4):457-67. doi: 10.2217/17460751.1.4.457. Regen Med. 2006. PMID: 17465838

2

Taking tissue-engineering principles into theater: augmentation of impacted allograft with human bone marrow stromal cells.

Tilley S, Bolland BJ, Partridge K, New AM, Latham JM, Dunlop DG, Oreffo RO. Tilley S, et al. Among authors: partridge k. Regen Med. 2006 Sep;1(5):685-92. doi: 10.2217/17460751.1.5.685. Regen Med. 2006. PMID: 17465735

3

Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering.

Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO. Yang X, et al. J Bone Miner Res. 2003 Jan;18(1):47-57. doi: 10.1359/jbmr.2003.18.1.47. J Bone Miner Res. 2003. PMID: 12510805 Free article.

4

Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies.

Partridge KA, Oreffo RO. Partridge KA, et al. Tissue Eng. 2004 Jan-Feb;10(1-2):295-307. doi: 10.1089/107632704322791934. Tissue Eng. 2004. PMID: 15009954 Review.

5

Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold.

Howard D, Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Howdle SM, Shakesheff KM, Oreffo RO. Howard D, et al. Among authors: partridge k. Biochem Biophys Res Commun. 2002 Nov 29;299(2):208-15. doi: 10.1016/s0006-291x(02)02561-5. Biochem Biophys Res Commun. 2002. PMID: 12437971

6

Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds.

Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO. Partridge K, et al. Biochem Biophys Res Commun. 2002 Mar 22;292(1):144-52. doi: 10.1006/bbrc.2002.6623. Biochem Biophys Res Commun. 2002. PMID: 11890685

7

Gene therapy used for tissue engineering applications.

Heyde M, Partridge KA, Oreffo RO, Howdle SM, Shakesheff KM, Garnett MC. Heyde M, et al. J Pharm Pharmacol. 2007 Mar;59(3):329-50. doi: 10.1211/jpp.59.3.0002. J Pharm Pharmacol. 2007. PMID: 17331336 Review.

8

Development of a slow non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 technique.

Heyde M, Partridge KA, Howdle SM, Oreffo RO, Garnett MC, Shakesheff KM. Heyde M, et al. Biotechnol Bioeng. 2007 Oct 15;98(3):679-93. doi: 10.1002/bit.21446. Biotechnol Bioeng. 2007. PMID: 17405179

9

Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines.

Christodoulides M, Makepeace BL, Partridge KA, Kaur D, Fowler MI, Weller RO, Heckels JE. Christodoulides M, et al. Infect Immun. 2002 Aug;70(8):4035-44. doi: 10.1128/IAI.70.8.4035-4044.2002. Infect Immun. 2002. PMID: 12117909 Free PMC article.

10

Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C(2)C(12) myotubes by dexamethasone: effect of the proteasome inhibitor MG-132.

Thompson MG, Thom A, Partridge K, Garden K, Campbell GP, Calder G, Palmer RM. Thompson MG, et al. Among authors: partridge k. J Cell Physiol. 1999 Dec;181(3):455-61. doi: 10.1002/(SICI)1097-4652(199912)181:3<455::AID-JCP9>3.0.CO;2-K. J Cell Physiol. 1999. PMID: 10528231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters